Blackstone Exclusive: New Privatization Offer for Drug Giant Explained

Blackstone is partnering with the leadership of I’rom Group Co. to privatize the Japanese pharmaceutical services giant.

The planned acquisition involves a tender offer of ¥2,800 per share, significantly above the recent close of ¥1,873, signaling a 50% premium. If successful, the deal will result in I’rom’s delisting, with Blackstone holding a 55% stake and the remaining 45% retained by